The funds will support the development of LoQus23’s lead candidate, its MutSβ inhibitor, as it enters clinical development.

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is ...

Researchers have discovered that the protein mutated in patients with Huntington’s disease doesn’t repair DNA as intended, ...

BPGbio to present novel Huntington's Disease and Alzheimer's Disease research at the Society for Neuroscience 2024 annual meeting.

The Food and Drug Administration has granted Fast Track designation to PTC518 for the treatment of Huntington disease (HD).

Past work by Yoo and his colleagues, who pioneered this transformation technique using small RNA molecules called microRNAs, has focused on understanding the development of Huntington's disease -; an ...

Researchers with McMaster University have discovered that the protein mutated in patients with Huntington's Disease doesn't repair DNA as intended, impacting the ability of brain cells to heal ...

Hundreds of walkers will lace up their shoes this weekend to raise money to battle Alzheimer’s and Huntington’s Disease.

Researchers have discovered that the protein mutated in Huntington’s Disease fails to properly repair DNA, leading to reduced brain cell healing.

The Huntington’s Disease Society of America’s Ohio Valley Chapter will raise funding and awareness about the disease with its annual Hope Walk, which will take place next month.

PTC Therapeutics, Inc. (PTCT) announced Thursday that the FDA has granted Fast Track designation to the PTC518 program for the ...

Cambridge biotech LoQus23 Therapeutics has closed a £35 million (c.$43m) Series A to advance its fight against Huntington’s ...